ZNL-0056
Product Specifications
Target
EGFR
Related Pathways
Tyrosine Kinase/Adaptors, JAK/STAT signaling, Angiogenesis
Bioactivity
ZNL-0056 is an orally active ATP-competitive inhibitor that targets the EGFR ATP-binding site, specifically Cys797 and Cys775. It selectively inhibits EGFR and its downstream signaling in H3255 cells. ZNL-0056 is applicable for cancer research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC042075-500 1x 500 µL
MyoD1 (Rhabdomyosarcoma Marker) (MYOD1/2075R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
